COYA
Price
$5.38
Change
-$0.22 (-3.93%)
Updated
Jan 17 closing price
Capitalization
89.89M
66 days until earnings call
KNSA
Price
$18.54
Change
+$0.15 (+0.82%)
Updated
Jan 17 closing price
Capitalization
1.34B
39 days until earnings call
Ad is loading...

COYA vs KNSA

Header iconCOYA vs KNSA Comparison
Open Charts COYA vs KNSABanner chart's image
Coya Therapeutics
Price$5.38
Change-$0.22 (-3.93%)
Volume$63.99K
Capitalization89.89M
Kiniksa Pharmaceuticals International
Price$18.54
Change+$0.15 (+0.82%)
Volume$482.34K
Capitalization1.34B
COYA vs KNSA Comparison Chart
Loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COYA vs. KNSA commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Hold and KNSA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (COYA: $5.38 vs. KNSA: $18.54)
Brand notoriety: COYA and KNSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 95% vs. KNSA: 133%
Market capitalization -- COYA: $89.89M vs. KNSA: $1.34B
COYA [@Biotechnology] is valued at $89.89M. KNSA’s [@Biotechnology] market capitalization is $1.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileKNSA’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • KNSA’s FA Score: 1 green, 4 red.
According to our system of comparison, both COYA and KNSA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 4 TA indicator(s) are bullish while KNSA’s TA Score has 3 bullish TA indicator(s).

  • COYA’s TA Score: 4 bullish, 3 bearish.
  • KNSA’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, COYA is a better buy in the short-term than KNSA.

Price Growth

COYA (@Biotechnology) experienced а -6.76% price change this week, while KNSA (@Biotechnology) price change was -6.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

COYA is expected to report earnings on Mar 26, 2025.

KNSA is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNSA($1.34B) has a higher market cap than COYA($89.9M). COYA (-6.108) and KNSA (-6.269) have similar YTD gains . COYA has higher annual earnings (EBITDA): -11.33M vs. KNSA (-24.4M). KNSA has more cash in the bank: 224M vs. COYA (31.1M). KNSA has higher revenues than COYA: KNSA (384M) vs COYA (9.55M).
COYAKNSACOYA / KNSA
Capitalization89.9M1.34B7%
EBITDA-11.33M-24.4M46%
Gain YTD-6.108-6.26997%
P/E RatioN/A164.54-
Revenue9.55M384M2%
Total Cash31.1M224M14%
Total DebtN/A10.6M-
FUNDAMENTALS RATINGS
KNSA: Fundamental Ratings
KNSA
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COYAKNSA
RSI
ODDS (%)
Bullish Trend 11 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
84%
Bullish Trend 11 days ago
76%
Momentum
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 11 days ago
74%
MACD
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 11 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 11 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
86%
Bearish Trend 11 days ago
82%
Advances
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 16 days ago
76%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 12 days ago
81%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
76%
Bearish Trend 11 days ago
80%
View a ticker or compare two or three
Ad is loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MQGIX47.850.21
+0.44%
MFS International Growth I
HIAOX16.430.07
+0.43%
Hartford International Opp HLS IA
GFVAX15.79N/A
N/A
Goldman Sachs Focused Value A
UIAGX69.15N/A
N/A
Victory Aggressive Growth Institutional
CDAZX7.52-0.01
-0.13%
Multi-Manager Directional Alt Strat Inst

COYA and

Correlation & Price change

A.I.dvisor tells us that COYA and IVVD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COYA and IVVD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
-3.93%
IVVD - COYA
30%
Poorly correlated
-7.49%
KNSA - COYA
29%
Poorly correlated
+0.82%
NTLA - COYA
29%
Poorly correlated
+0.85%
FBIO - COYA
29%
Poorly correlated
-2.09%
IOVA - COYA
28%
Poorly correlated
+2.60%
More

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with FATE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.82%
FATE - KNSA
44%
Loosely correlated
+1.60%
ABVC - KNSA
40%
Loosely correlated
-2.01%
NTLA - KNSA
40%
Loosely correlated
+0.85%
BEAM - KNSA
39%
Loosely correlated
+0.17%
TRDA - KNSA
39%
Loosely correlated
+1.20%
More